Bin Mao Selected Research

cytisine

11/2018

Cytisine-Pterocarpan-Derived Compounds: Biomimetic Synthesis and Apoptosis-Inducing Activity in Human Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin Mao Research Topics

Disease

2	Myocardial Infarction 02/2022 - 12/2013
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 12/2013
2	Osteogenesis Imperfecta (Lobstein Disease) 01/2020 - 01/2019
2	Infections 07/2019 - 07/2018
1	Acute Coronary Syndrome 02/2022
1	Carcinogenesis 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Primary Ovarian Insufficiency 01/2022
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	COVID-19 01/2021
1	Anemia 12/2020
1	Developmental Bone Diseases (Bone Dysplasia) 01/2019
1	Hearing Loss (Hearing Impairment) 01/2019
1	Dentigerous Cyst 12/2018
1	Cysts 12/2018
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Human Influenza (Influenza) 07/2018
1	Epidermolytic Palmoplantar Keratoderma 02/2018
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2018
1	Carcinoma (Carcinomatosis) 12/2017
1	Pulmonary Atelectasis 09/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2008
1	Congenital Heart Defects (Congenital Heart Defect) 04/2004
1	Subacute Bacterial Endocarditis 04/2004
1	Aortic Diseases 04/2004
1	Aortic Valve Prolapse 04/2004
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2004
1	Hypothermia 04/2004

Drug/Important Bio-Agent (IBA)

2	C-Reactive ProteinIBA 02/2022 - 01/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2019
2	Collagen Type I (Type I Collagen)IBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 12/2018 - 06/2008
1	CytokinesIBA 02/2022
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 02/2022
1	SurvivinIBA 01/2022
1	AntigensIBA 01/2022
1	Biological ProductsIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CyclinsIBA 01/2022
1	Cyclin D1IBA 01/2022
1	CateninsIBA 01/2022
1	AnticoagulantsIBA 04/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	GATA Transcription FactorsIBA 12/2020
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 12/2020
1	Adenosine (Adenocard)FDA LinkGeneric 12/2020
1	MicroRNAs (MicroRNA)IBA 07/2019
1	RNA (Ribonucleic Acid)IBA 07/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2019
1	alpha2 Subunit Collagen Type IIBA 01/2019
1	cytisineIBA 11/2018
1	Antiviral Agents (Antivirals)IBA 07/2018
1	Ribavirin (Virazole)FDA LinkGeneric 07/2018
1	Pharmaceutical PreparationsIBA 07/2018
1	Keratin-9 (Keratin 9)IBA 02/2018
1	3-(2-carboxyindol-3-yl)propionic acidIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2013
1	ChemokinesIBA 12/2013
1	Capsules (Microcapsules)IBA 06/2008

Therapy/Procedure

2	Aftercare (After-Treatment) 12/2018 - 06/2008
1	Percutaneous Coronary Intervention 02/2022
1	Sutures (Suture) 12/2018
1	Traction 12/2018
1	Catheters 12/2017
1	Extracorporeal Membrane Oxygenation 09/2017
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2017
1	Transplantation 04/2004